MDM4 and melanoma: Interestingly, in human melanoma cell lines and in melanoma patient-derived xenograft mouse models, antisense oligonucleotide-mediated skipping of exon 6 decreased MDM4 levels, inhibited melanoma growth, and enhanced sensitivity to various anti-melanoma therapeutics [83].